Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released Aug 8, 2022, after the close
10-Q filed Aug 8, 2022, 39 days after period end · 0000950170-22-015536
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $51.58M | — | — | — |
| Net Income | $18.47M | -$83.79M | -$77.46M | -$74.33M |
| EPS Diluted |
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR
| $0.18 |
| -$0.91 |
| -$1.14 |
| -$1.60 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.